April 12, 2021 M&A, Partnerships

Avantor to Acquire Ritter GmbH and its Affiliates; Expands Proprietary Offering for Diagnostic and Drug Discovery Workflows

APRIL 12, 2021- Ritter is a fast-growing, technology leader in high-precision consumables– Combines Ritter’s liquid handling consumables platform for clinical diagnostic testing and life sciences research with Avantor’s offerings for critical lab automation workflows and leading global customer channel– Transaction expected to be immediately accretive to Adjusted Earnings per Share (EPS) upon closure and anticipated... Read more

April 12, 2021 Bio/Pharma/CRO Liq. Handling & Robotics Product Launch

Expansion of Lonza’s Automated Robotic Solution for Endotoxin Testing Automates Sustainable Recombinant Factor C Assay

12 Apr 2021 Downloads News Release PDF The PyroTec® PRO Automated Solution combined with the PyroWave® Reader option expands the range of endotoxin testing types available on the platform to now include the PyroGene® Recombinant Factor C assay The addition of the PyroWave® XM Fluorescent Reader complements the existing absorbance readers used in traditional LAL-based assays Full integration with... Read more

April 12, 2021 Clinical Research/Diagn. M&A, Partnerships

Abcam and MEDx extend precision medicine strategic partnership

Cambridge, UK and Shanghai, China, 12 April : Today Abcam (AIM: ABC; NASDAQ: ABCM), a global innovator in life science reagents and tools, and MEDxTranslational Medicine (MEDx), formerly QIAGEN (Suzhou) Translational Medicine Co., Ltd., a company dedicated to developing companion diagnostics and precision medicine, announced the extension of their strategic partnership to include the co-development and commercialization of key... Read more

April 12, 2021 Acad, Gov/Utilities Lab Top-10 Liq. Handling & Robotics Microscopy Product Launch

FDA Authorizes New High-Throughput, Automated System for Leading COVID-19 Test

The Amplitude Solution with the TaqPath COVID-19 High-Throughput Combo Kit enables laboratories to rapidly scale high-sensitivity PCR testing capacity as schools and employers seek increased testing to support reopening strategies WALTHAM, Mass., April 12, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that the U.S. Food and Drug... Read more

April 12, 2021 Bio/Pharma/CRO

Phase III prevention trial showed subcutaneous administration of investigational antibody cocktail casirivimab and imdevimab reduced risk of symptomatic COVID-19 infections by 81%

Among individuals who still experienced symptomatic infections, those who received casirivimab and imdevimab were able to clear the virus faster and had much shorter symptom duration In a cohort of recently-infected asymptomatic patients, casirivimab and imdevimab reduced the overall risk of progressing to symptomatic COVID-19 by 31% Detailed results will be shared with regulatory authorities... Read more

April 11, 2021 Clinical Research/Diagn. Liq. Handling & Robotics M&A, Partnerships

Diasorin To Acquire Luminex Corporation for USD 37.00 per Share or Approximately USD 1.8 Billion

– Provides Access To Proven Luminex Multiplexing Technology And Molecular Testing Solutions To Be Used In Unique Testing Panels, Generating Critical Mass In The Molecular Diagnostics Space – Sets The Ground For New Partnerships And Business Development Opportunities Through Life Science Offerings – Broadens DiaSorin’s Presence In The U.S. – Accelerates Luminex Technology And Solutions’... Read more

April 8, 2021 Life Science Tools Product Launch

Bio-Techne Announces Commercial Release of Abby Automated Western System for Simple Western and Introduces Stellar Modules for Jess

Abby is the next generation chemiluminescence Western protein analyzer and Stellar modules set the standard for fluorescence sensitivity MINNEAPOLIS, April 8, 2021 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) today announced that ProteinSimple, a Bio-Techne brand, released Abby, its next generation chemiluminescence system that automates traditional Western blotting.  This latest addition to the Simple Western product family offers... Read more

April 8, 2021 Product Launch

New Roche data at 2021 AAN highlight impact and breadth of expanding neuroscience portfolio

EVRYSDI 2-year FIREFISH Part 2 data show improvement in motor function in infants with Type 1 spinal muscular atrophy (SMA) OCREVUS data show its consistent benefit on slowing disease progression in relapsing multiple sclerosis (RMS) and primary progressive MS (PPMS) Data for ENSPRYNG in neuromyelitis optica spectrum disorder (NMOSD) reinforce safety and efficacy, including in... Read more